All Comments by Paul Coleman
- Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
- Neuropathology of three clinical cases prospectively diagnosed as dementia with Lewy bodies.
- Alzheimer neuropathologic alterations in aged cognitively normal subjects.
- A population-based study on blood pressure and brain atrophy in 85-year-olds.
- Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease.
- Diabetes and dementia in long-term care.
- Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
- Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere
- Ubiquitin, cellular inclusions and their role in neurodegeneration.
- High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.
- The Alzheimerization of aging: a brief update.
- Effect of Alzheimer's brain extracts on dynein immunoreactivity in PC12 cells.
- Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus.
- Visual loss and getting lost in Alzheimer's disease.
- Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.